<sup>131</sup>I治疗儿童及青少年Graves病

欧阳萌

¹³¹I治疗儿童及青少年Graves病

欧阳萌

文章导航 > 国际放射医学核医学杂志 > 2004, 28 > 2: (70-73)

引用本文:

Citation:

¹³¹I治疗儿童及青少年Graves病

欧阳萌

100730, 中国医学科学院
中图分类号: R817.5

¹³¹I therapy of Graves' disease in childhood and adolescence

OU Yang-meng

Department of Nuclear Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
CLC number: R817.5

摘要: 抗甲状腺药物、手术、放射性碘是儿童及青少年Graves病的3种治疗方法。近60年的医疗实践证明,¹³¹I治疗是安全、有效的,应当作为首选治疗方法。
- Graves病 /
- 儿童及青少年 /
- 放射性碘治疗
Abstract: Three therapy options including antithyroid drugs, surgery and radioiodine are available for Graves' hyperthyroidism in childhood and adolescence. Nearly 60 years practice has proven that radioiodine is safe and effective and should be the first, line therapy.
- Graves' disease /
- childhood and adolescence /
- radioiodine treatment
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Wilson MA. Textbook of nuclear medicine[M]. Loppin-cottRaven Publishers, Philadelphia, 1998. 153-187.
[2]	Cheetham TD, Hughes IA, Bames ND. Treatment of hyperthyroidism in young people[J]. Arch Dis Chold, 1998, 78(3):207-209.
[3]	ong GWK, Cheng PS. Increasing incidence of child-hood Graves' disease in Hong Kong:A follow-up study[J]. Clin Endocrinol, 2001, 54:547-550.
[4]	Rivkees SA, Sklar C, Freemark M. The management of Graves' disease in children, with special empha-sis on radioiodine treatment[J]. J Clin Endocrinol Metab, 1998, 83:3767-3776.
[5]	Raza J, Hindmarsh PC, Brook CGD. Thyrotoxicosis in children:thirty years experience[J]. Acta Paediatr, 1999, 88:937-941.
[6]	Koch CA, Sarlis NJ. The spectrum of thyroid diseases in childhood and its evolution during transition to adulthood:natural history, diagnosis, differential diagno-sis and management[J]. J Endocrinol Invest, 2001, 24:659-675.
[7]	Kraimps JL, Bouin-Pineau MH, Mathonner M, et al. Multicentre study of thyroid nodules in patients with Graves'disease[J]. BrJ Surg, 2000, 87(8):1111-1110.
[8]	Kurihara H. Total thyroidectomy for the treatment of hyperthyroidism in patients with ophthalmopathy[J]. Thyroid,2002, 12:265-267.
[9]	Murakami Y, Takamatsu J, Sakane S, et al. Changes in thyroid volume in response to radioactive indine for graves'hyperthroidism correlated with activity of thy-roid-stimulating antibody and treatment outcome[J]. J Clin Endocrinol Metab, 1996, 81:3257-3260.
[10]	Allahabadia A, Daykin J, Sheppard MC, et al. Radioiodine treatment of factors for outcome[J]. J Clin Endocrinol Metab,2001, 86:3611-3617.
[11]	Kadmon PM, Noto RB, Boney CM, et al. Thyroid storm in a child following radioactive iodine therapy:A consequence of RAI versus withdrawal of antithy-roid medication[J]. J Clin Endocrinol Metab, 2001, 86:1865-1867.
[12]	Schlumberger M, De Vathaire F. 131-iodine:medical use,carcinogenic and genetic effects[J]. Ann Endocrinol (Paris)1996, 57(3):166-176.
[13]	Pauwels EK, Smit JWA, Slats A, et al. Health effects of therapeutic use of ¹³¹I in hyperthyroidism[J]. QJ Nucl Med,2000, 44:333-339.
[14]	Freitas JE. The role of nuclear medicine in the management of Graves' disease[J]. QJ Nucl Med, 1999,43:297-306.
[15]	WGruneiro-Papendieck L, Chiesa A, Finkielsain G, et al. Pediatric Graves' disease:outcome and treatment[J]. J Pediatr Endocrinol Metab, 2003, 16:1249-1255.
[16]	Chan W, Wong GWK, Fan DSP, et al. Ophthalmopathy in childhood Graves' disease[J]. Br J Ophthalmol, 2002, 86:740-742.
[17]	Wiersinga WM. Preventing Graves' ophthalmopathy[J]. N Engl J Med, 1998, 338:121-122.
[18]	Marcocci C, Bartalena M, Tanda L, et al. Graves' ophthalmopathy and ¹³¹I therapy[J]. Q J Nucl Med, 1999, 43:307-312.
[19]	Kraiem Z, Newfield RS. Graves' disease in childhood[J]. J Pediatr Endocrinol Metab, 2001, 14(3):229-243.

[1]	蔡敏 , 李险峰 , 陈海滨 , 李思进 . ¹³¹Ⅰ治疗Graves病783例疗效观察及影响因素分析. 国际放射医学核医学杂志, 2008, 32(2): 75-78.
[2]	陈立波 . 钠/碘同向转运体与放射性碘治疗. 国际放射医学核医学杂志, 2001, 25(6): 258-261.
[3]	李倩 . 钠/碘转运体的临床实用价值. 国际放射医学核医学杂志, 2003, 27(2): 56-58,65.
[4]	张静 , 贾茜 , 赵傲梅 , 杨爱民 . 分化型甲状腺癌放射性碘治疗敏感性及其影响因素的研究进展. 国际放射医学核医学杂志, 2022, 46(4): 245-253. doi: 10.3760/cma.j.cn121381-202103030-00168
[5]	柳卫 , 张满达 , 王铁生 . 钠/碘同向转运体. 国际放射医学核医学杂志, 2001, 25(2): 49-52.
[6]	黄蕤 . NIS基因转染肿瘤细胞介导¹³¹I治疗. 国际放射医学核医学杂志, 2001, 25(5): 204-209.
[7]	牟联超 , 李先映 , 石彩虹 . ¹³¹Ⅰ治疗青少年Graves病58例临床分析. 国际放射医学核医学杂志, 2010, 34(5): 299-301. doi: 10.3760/cma.j.issn.1673-4114.2010.05.013
[8]	丁昊 , 叶斌 , 雷勇 . 增强DTC病灶摄取¹³¹I功能的措施. 国际放射医学核医学杂志, 2001, 25(4): 145-148.
[9]	邢岩 . TPO基因及其应用研究. 国际放射医学核医学杂志, 2002, 26(6): 248-252.
[10]	郑艳 , 赵德善 , 付松海 , 冯菲 , 耿会霞 , 孙琦婷 , 陆克义 , 李保军 , 李思进 . 儿童和青少年Graves甲亢患者¹³¹I治疗剂量的分析研究. 国际放射医学核医学杂志, 2013, 37(2): 69-73. doi: 10.3760/cma.j.issn.1673-4114.2013.02.002